Concepedia

Ross Mabon

RM

15

Publications

1.4K

Citations

15

H-Index

1999

Active since

Affiliations

Lexicon Pharmaceuticals (United States)(Current)

Northwestern University

ExxonMobil (United States)

University of Reading

Ross Mabon is an author at Lexicon Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1999–2018

15

Publications

15

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Brian Zambrowicz, J Freiman, Phil Brown et al. · Clinical Pharmacology & Therapeutics · 2012 · 235 citations · Full text

A mechanistic model of fast pyrolysis of hemicellulose

Xiaowei Zhou, Wen‐Jun Li, Ross Mabon et al. · Energy & Environmental Science · 2018 · 223 citations

, , +9

A Chondroitin Sulfate Small Molecule that Stimulates Neuronal Growth

Sarah E. Tully, Ross Mabon, Cristal I. Gama et al. · Journal of the American Chemical Society · 2004 · 167 citations

, , +17

3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor

John W. Huffman, Ross Mabon, Ming‐Jung Wu et al. · Bioorganic & Medicinal Chemistry · 2003 · 147 citations

, , +8

Alcohols, ethers and phenols

T. W. George, Ross Mabon, Gemma Sweeney et al. · Journal of the Chemical Society Perkin Transactions 1 · 2000 · 81 citations

, , +8

Rows per page

1–5 of 15